Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Aug;40(2):145–152.

Respiratory depression following morphine and morphine-6-glucuronide in normal subjects.

P I Thompson 1, S P Joel 1, L John 1, J A Wedzicha 1, M Maclean 1, M L Slevin 1
PMCID: PMC1365174  PMID: 8562297

Abstract

1. Morphine 6-glucuronide (M6G) is a metabolite of morphine with analgesic activity. A double-blind, randomised comparison of the effects of morphine and M6G on respiratory function was carried out in 10 normal subjects after i.v. morphine (10 mg 70 kg-1) or M6G (1, 3.3 and 5 mg 70 kg-1). Analgesic potency was also assessed using an ischaemic pain test and other toxic effects were monitored. 2. Following morphine there was a significant increase in arterial PCO2, as measured by blood gases 45 min post dose (0.54 +/- 0.24 (s.d.) kPa, P < 0.001), and in transcutaneous PCO2 from 15 min post dose until the end of the study period (4 h), whereas blood gas and transcutaneous PCO2 were unchanged after M6G at 1.0, 3.3 and 5.0 mg 70 kg-1. This increased PCO2 following morphine was associated with an increase in expired CO2 concentration (FECO2) (0.20 +/- 0.14% expired air at 15 min post dose, P = 0.002), compared with small but significant reductions in FECO2 following morphine 6-glucuronide (-0.15 +/- 0.17% at 1 mg 70 kg-1 P = 0.030, -0.14 +/- 0.15% at 3.3 mg 70 kg-1 P = 0.017, -0.18 +/- 0.11% at 5 mg 70 kg-1 P = 0.024). Maximum transcutaneous PCO2 was significantly increased after morphine (0.63 +/- 0.28 kPa P = 0.009), but was not changed after M6G at 1 mg (0.10 +/- 0.34 kPa P = 0.11) 3.3 mg (0.06 +/- 0.37 kPa P = 0.34) or 5 mg (0.26 +/- 0.07 kPa P = 0.10).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott F. V., Palmour R. M. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sci. 1988;43(21):1685–1695. doi: 10.1016/0024-3205(88)90479-1. [DOI] [PubMed] [Google Scholar]
  2. Chen Y., Mestek A., Liu J., Hurley J. A., Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol. 1993 Jul;44(1):8–12. [PubMed] [Google Scholar]
  3. Gong Q. L., Hedner J., Björkman R., Hedner T. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain. 1992 Feb;48(2):249–255. doi: 10.1016/0304-3959(92)90065-J. [DOI] [PubMed] [Google Scholar]
  4. Hanks G. W., Hoskin P. J., Aherne G. W., Turner P., Poulain P. Explanation for potency of repeated oral doses of morphine? Lancet. 1987 Sep 26;2(8561):723–725. doi: 10.1016/s0140-6736(87)91083-x. [DOI] [PubMed] [Google Scholar]
  5. Hanna M. H., Peat S. J., Woodham M., Knibb A., Fung C. Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine. Br J Anaesth. 1990 May;64(5):547–550. doi: 10.1093/bja/64.5.547. [DOI] [PubMed] [Google Scholar]
  6. Hucks D., Thompson P. I., McLoughlin L., Joel S. P., Patel N., Grossman A., Rees L. H., Slevin M. L. Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide. Br J Cancer. 1992 Jan;65(1):122–126. doi: 10.1038/bjc.1992.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jennett S. Assessment of respiratory effects of analgesic drugs. Br J Anaesth. 1968 Oct;40(10):746–756. doi: 10.1093/bja/40.10.746. [DOI] [PubMed] [Google Scholar]
  8. Jordan C., Lehane J. R., Robson P. J., Jones J. G. A comparison of the respiratory effects of meptazinol, pentazocine and morphine. Br J Anaesth. 1979 Jun;51(6):497–502. doi: 10.1093/bja/51.6.497. [DOI] [PubMed] [Google Scholar]
  9. Konieczko K. M., Jones J. G., Barrowcliffe M. P., Jordan C., Altman D. G. Antagonism of morphine-induced respiratory depression with nalmefene. Br J Anaesth. 1988 Sep;61(3):318–323. doi: 10.1093/bja/61.3.318. [DOI] [PubMed] [Google Scholar]
  10. Littman G. S., Walker B. R., Schneider B. E. Reassessment of verbal and visual analog ratings in analgesic studies. Clin Pharmacol Ther. 1985 Jul;38(1):16–23. doi: 10.1038/clpt.1985.127. [DOI] [PubMed] [Google Scholar]
  11. Ohnhaus E. E., Adler R. Methodological problems in the measurement of pain: a comparison between the verbal rating scale and the visual analogue scale. Pain. 1975 Dec;1(4):379–384. doi: 10.1016/0304-3959(75)90075-5. [DOI] [PubMed] [Google Scholar]
  12. Osborne R. J., Joel S. P., Slevin M. L. Morphine intoxication in renal failure: the role of morphine-6-glucuronide. Br Med J (Clin Res Ed) 1986 Jun 14;292(6535):1548–1549. doi: 10.1136/bmj.292.6535.1548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Osborne R., Joel S., Grebenik K., Trew D., Slevin M. The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clin Pharmacol Ther. 1993 Aug;54(2):158–167. doi: 10.1038/clpt.1993.127. [DOI] [PubMed] [Google Scholar]
  14. Osborne R., Joel S., Trew D., Slevin M. Analgesic activity of morphine-6-glucuronide. Lancet. 1988 Apr 9;1(8589):828–828. doi: 10.1016/s0140-6736(88)91691-1. [DOI] [PubMed] [Google Scholar]
  15. Osborne R., Thompson P., Joel S., Trew D., Patel N., Slevin M. The analgesic activity of morphine-6-glucuronide. Br J Clin Pharmacol. 1992 Aug;34(2):130–138. doi: 10.1111/j.1365-2125.1992.tb04121.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pasternak G. W., Bodnar R. J., Clark J. A., Inturrisi C. E. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 1987 Dec 28;41(26):2845–2849. doi: 10.1016/0024-3205(87)90431-0. [DOI] [PubMed] [Google Scholar]
  17. Pasternak G. W., Childers S. R., Snyder S. H. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro. J Pharmacol Exp Ther. 1980 Sep;214(3):455–462. [PubMed] [Google Scholar]
  18. Pasternak G. W., Wood P. J. Multiple mu opiate receptors. Life Sci. 1986 May 26;38(21):1889–1898. doi: 10.1016/0024-3205(86)90217-1. [DOI] [PubMed] [Google Scholar]
  19. Paul D., Standifer K. M., Inturrisi C. E., Pasternak G. W. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989 Nov;251(2):477–483. [PubMed] [Google Scholar]
  20. Peat S. J., Hanna M. H., Woodham M., Knibb A. A., Ponte J. Morphine-6-glucuronide: effects on ventilation in normal volunteers. Pain. 1991 Apr;45(1):101–104. doi: 10.1016/0304-3959(91)90170-3. [DOI] [PubMed] [Google Scholar]
  21. Rothman R. B., Jacobson A. E., Rice K. C., Herkenham M. Autoradiographic evidence for two classes of mu opioid binding sites in rat brain using [125I]FK33824. Peptides. 1987 Nov-Dec;8(6):1015–1021. doi: 10.1016/0196-9781(87)90130-6. [DOI] [PubMed] [Google Scholar]
  22. Shimomura K., Kamata O., Ueki S., Ida S., Oguri K. Analgesic effect of morphine glucuronides. Tohoku J Exp Med. 1971 Sep;105(1):45–52. doi: 10.1620/tjem.105.45. [DOI] [PubMed] [Google Scholar]
  23. Smith G. M., Egbert L. D., Markowitz R. A., Mosteller F., Beecher H. K. An experimental pain method sensitive to morphine in man: the submaximum effort tourniquet technique. J Pharmacol Exp Ther. 1966 Nov;154(2):324–332. [PubMed] [Google Scholar]
  24. Smith G. M., Lowenstein E., Hubbard J. H., Beecher H. K. Experimental pain produced by the submaximum effort tourniquet technique: further evidence of validity. J Pharmacol Exp Ther. 1968 Oct;163(2):468–474. [PubMed] [Google Scholar]
  25. Smith M. T., Watt J. A., Cramond T. Morphine-3-glucuronide--a potent antagonist of morphine analgesia. Life Sci. 1990;47(6):579–585. doi: 10.1016/0024-3205(90)90619-3. [DOI] [PubMed] [Google Scholar]
  26. Spiro S. G., Dowdeswell I. R. Arterialized ear lobe blood samples for blood gas tensions. Br J Dis Chest. 1976 Oct;70(4):263–268. doi: 10.1016/0007-0971(76)90042-5. [DOI] [PubMed] [Google Scholar]
  27. Säwe J., Odar-Cederlöf I. Kinetics of morphine in patients with renal failure. Eur J Clin Pharmacol. 1987;32(4):377–382. doi: 10.1007/BF00543973. [DOI] [PubMed] [Google Scholar]
  28. Wallenstein S. L., Heidrich G., 3rd, Kaiko R., Houde R. W. Clinical evaluation of mild analgesics: the measurement of clinical pain. Br J Clin Pharmacol. 1980 Oct;10 (Suppl 2):319S–327S. doi: 10.1111/j.1365-2125.1980.tb01816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES